PharmaCyte Biotech Inc (PMCB)
2.19
+0.06
(+2.82%)
USD |
NASDAQ |
May 02, 16:00
2.19
0.00 (0.00%)
After-Hours: 19:06
PharmaCyte Biotech Price to Book Value: 0.5909 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 0.5747 |
| April 30, 2024 | 0.572 |
| April 29, 2024 | 0.572 |
| April 26, 2024 | 0.5693 |
| April 25, 2024 | 0.572 |
| April 24, 2024 | 0.5935 |
| April 23, 2024 | 0.5747 |
| April 22, 2024 | 0.5989 |
| April 19, 2024 | 0.572 |
| April 18, 2024 | 0.5935 |
| April 17, 2024 | 0.572 |
| April 16, 2024 | 0.5801 |
| April 15, 2024 | 0.5693 |
| April 12, 2024 | 0.6016 |
| April 11, 2024 | 0.6205 |
| April 10, 2024 | 0.6097 |
| April 09, 2024 | 0.6205 |
| April 08, 2024 | 0.6448 |
| April 05, 2024 | 0.6529 |
| April 04, 2024 | 0.6799 |
| April 03, 2024 | 0.6772 |
| April 02, 2024 | 0.6691 |
| April 01, 2024 | 0.6596 |
| March 28, 2024 | 0.6394 |
| March 27, 2024 | 0.6583 |
| Date | Value |
|---|---|
| March 26, 2024 | 0.6583 |
| March 25, 2024 | 0.6691 |
| March 22, 2024 | 0.6583 |
| March 21, 2024 | 0.6502 |
| March 20, 2024 | 0.6421 |
| March 19, 2024 | 0.5774 |
| March 18, 2024 | 0.5423 |
| March 15, 2024 | 0.5261 |
| March 14, 2024 | 0.554 |
| March 13, 2024 | 0.5378 |
| March 12, 2024 | 0.535 |
| March 11, 2024 | 0.5459 |
| March 08, 2024 | 0.5595 |
| March 07, 2024 | 0.5568 |
| March 06, 2024 | 0.5513 |
| March 05, 2024 | 0.5513 |
| March 04, 2024 | 0.5568 |
| March 01, 2024 | 0.5649 |
| February 29, 2024 | 0.5703 |
| February 28, 2024 | 0.5703 |
| February 27, 2024 | 0.5486 |
| February 26, 2024 | 0.5649 |
| February 23, 2024 | 0.5595 |
| February 22, 2024 | 0.5595 |
| February 21, 2024 | 0.5595 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3297
Minimum
Jul 28 2023
18.53
Maximum
Jan 31 2020
4.161
Average
0.8309
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.315 |
| AIM ImmunoTech Inc | 2.109 |
| IGC Pharma Inc | 3.590 |
| NovaBay Pharmaceuticals Inc | 1.966 |
| Protalix BioTherapeutics Inc | 2.535 |
Price to Book Value Related Metrics
| PS Ratio | 656.15 |
| Price | 2.19 |
| Earnings Yield | -54.79% |
| Market Cap | 18.54M |